|
|
Volumn 63, Issue SUPPL. 2, 2006, Pages
|
|
Impact of the Medicare Prescription Drug Improvement and Modernization Act on the management of colorectal cancer
|
|
Author keywords
Antineoplastic agents; Biologicals; Colorectal neoplasms; Health benefit programs; Laws; Medicare Prescription Drug Improvement and Modernization Act; Reimbursement
|
|
Indexed keywords
ANTIHISTAMINIC AGENT;
ANTINEOPLASTIC AGENT;
APREPITANT;
FENTANYL;
FLUOROURACIL;
FOLINIC ACID;
NARCOTIC ANALGESIC AGENT;
NEUROKININ 1 RECEPTOR ANTAGONIST;
NOVEL ERYTHROPOIESIS STIMULATING PROTEIN;
PHENOTHIAZINE DERIVATIVE;
PROCHLORPERAZINE;
RECOMBINANT ERYTHROPOIETIN;
RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;
SEROTONIN 3 ANTAGONIST;
TRIMETHOBENZAMIDE;
ALOPECIA;
ANEMIA;
CANCER CHEMOTHERAPY;
CANCER PAIN;
CANCER PALLIATIVE THERAPY;
COLORECTAL CANCER;
CONFERENCE PAPER;
HEALTH CARE ACCESS;
HEALTH CARE DELIVERY;
HEALTH CARE PERSONNEL;
HUMAN;
LAW;
MEDICARE;
NAUSEA AND VOMITING;
NEUTROPENIA;
OUTPATIENT CARE;
PATIENT;
PRESCRIPTION;
PRIORITY JOURNAL;
REIMBURSEMENT;
TREATMENT OUTCOME;
|
|
EID: 33646404650
PISSN: 10792082
EISSN: None
Source Type: Journal
DOI: 10.2146/ajhp060114 Document Type: Conference Paper |
|
Times cited : (7)
|
|
References (3)
|
